Manejo de la dislipemia aterogénica en Atención Primariadescripción de la práctica clínica habitual (Estudio Avanza)

  1. Jessica Capón Álvarez
Zuzendaria:
  1. Jesús Seco Calvo Zuzendaria
  2. Ángel Díaz Rodríguez Zuzendaria

Defentsa unibertsitatea: Universidad de León

Fecha de defensa: 2021(e)ko urtarrila-(a)k 28

Epaimahaia:
  1. José L. Mauriz Presidentea
  2. Vicente Rodríguez Pérez Idazkaria
  3. Luis Alberto Rodríguez Arroyo Kidea
Saila:
  1. ENFERMERÍA Y FISIOTERAPIA

Mota: Tesia

Laburpena

Atherogenic Dyslipemia (DA) is an alteration of lipid and lipoprotein metabolism. It is characterized by the presence of low levels of cholesterol transported by high density lipoproteins (HDL), hypertriglyceridemia and a high proportion of LDL (LDL: low density lipoproteins) small and dense, with or without a moderate increase in cLDL. This type of dyslipemia is associated with a high cardiovascular risk and contributes significantly to lipid residual vascular risk. It is also a very common lipoprotic phenotype and is associated with obesity, insulin resistance, coronary heart disease, metabolic syndrome, or type 21 diabetes mellitus (DM) .